Since TGF-β1 is present in squamous carcinomas, it is possible that latency associated peptide may modulate malignant keratinocyte behaviour independently from the classical TGF-β signalling pathways through its interaction with integrins. The gene discussed is TGFB1; the disease is squamous cell carcinoma.